mTOR (Mechanistic Target of Rapamycin) Inhibition Decreases Mechanosignaling, Collagen Accumulation, and Stiffening of the Thoracic Aorta in Elastin-Deficient Mice-Reference-Cited by-同舟云学术

mTOR (Mechanistic Target of Rapamycin) Inhibition Decreases Mechanosignaling, Collagen Accumulation, and Stiffening of the Thoracic Aorta in Elastin-Deficient Mice

Published:2017-09 Issue:9 Volume:37 Page:1657-1666
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:Arterioscler Thromb Vasc Biol.

Author:

Jiao Yang¹,Li Guangxin¹,Li Qingle¹,Ali Rahmat¹,Qin Lingfeng¹,Li Wei¹,Qyang Yibing¹,Greif Daniel M.¹,Geirsson Arnar¹,Humphrey Jay D.¹,Tellides George¹

Affiliation:

1. From the Department of Surgery (Y.J., G.L., Q.L., R.A., L.Q., W.L., A.G., G.T.), Department of Internal Medicine (Y.Q., D.M.G.), and Vascular Biology and Therapeutics Program (Y.Q., D.M.G., A.G., J.D.H., G.T.), Yale University School of Medicine, New Haven, CT; Department of Vascular Surgery, Peking University People’s Hospital, Beijing, P. R. China (Y.J., Q.L., W.L.); Department of Biomedical Engineering, Yale University, New Haven, CT (J.D.H.); and Veterans Affairs Connecticut Healthcare System,...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome

2. Evaluation of arterial stiffness in children with Williams syndrome: Does it play a role in evolving hypertension?

3. Increased arterial stiffness in children with Williams syndrome and normal blood pressure

4. Williams Syndrome Predisposes to Vascular Stiffness Modified by Antihypertensive Use and Copy Number Changes in NCF1

5. Supravalvular aortic stenosis. Clinical and pathologic observations in six patients.;O’Connor WN;Arch Pathol Lab Med,1985

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De Novo Elastin Assembly Alleviates Development of Supravalvular Aortic Stenosis—Brief Report;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-07

2. Matrisome and Immune Pathways Contribute to Extreme Vascular Outcomes in Williams–Beuren Syndrome;Journal of the American Heart Association;2024-02-06

3. Everolimus combined with PD-1 blockade inhibits progression of triple-negative breast cancer;Cellular Signalling;2023-09

4. Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats;Journal of Lipid and Atherosclerosis;2023

5. Pathway analysis identifies novel non-synonymous variants contributing to extreme vascular outcomes in Williams-Beuren syndrome;2022-09-22